Among MYC cofactors or MYC transcriptional activators, analysis of publicly available MM datasets showed a significant inverse correlation only between miR-22 expression and MYCBP, thus suggesting its pivotal role as potential mediator of miR-22-mediated MYC downregulation in MM cells (Figure 3a). The gene discussed is MYC; the disease is Miyoshi myopathy.